Characteristics | Total | Retained | Defaulting from care | Viral load suppression (copies/ml) | |||
---|---|---|---|---|---|---|---|
Alive | LTFU | Died | Total | ≤ 1000 | > 1000 | ||
n (%) | n (%) | N (%) | n (%) | n (%) | n (%) | n (%) | |
Median age (IQR) | 41 (33,49) | ||||||
Age category(year) | |||||||
 15–29 | 327 (19) | 300 (92) | 24 (7) | 3 (1) | 327 (19) | 242 (74) | 85 (26) |
 30–39 | 426 (25) | 390 (92) | 28 (7) | 8 (2) | 426 (25) | 344 (81) | 82 (19) |
 40–59 | 841 (50) | 785 (93) | 35 (4) | 21 (2) | 842 (50) | 718 (85) | 124 (15) |
 60+ | 94 (6) | 87 (93) | 2 (2) | 5 (5) | 94 (6) | 84 (89) | 10 (11) |
 Total | 1688 (100) | 1562 (93) | 89 (5) | 37 (2) | 1689 (100) | 1388 (82) | 301 (18) |
Sex | |||||||
 Female | 1031 (61) | 952 (92) | 55 (5) | 24 (2) | 1032 (61) | 866 (84) | 166 (16) |
 Male | 657 (39) | 610 (93) | 34 (5) | 13 (2) | 657 (39) | 522 (79) | 135 (21) |
 Total | 1688 (100) | 1562 (93) | 89 (5) | 37 (2) | 1689 (100) | 1388 (82) | 301 (18) |
Marital status | |||||||
 Single | 344 (20) | 309 (90) | 27 (8) | 8 (2) | 344 (20) | 259 (75) | 85 (25) |
 Married/Cohabitating | 648 (38) | 602 (93) | 30 (5) | 16 (2) | 649 (38) | 540 (83) | 109 (17) |
 separated/Divorced | 98 (6) | 89 (91) | 7 (7) | 2 (2) | 98 (6) | 86 (88) | 12 (12) |
 Widowed | 226 (13) | 214 (95) | 6 (3) | 6 (3) | 226 (13) | 198 (88) | 28 (12) |
 Missing | 372 (22) | 348 (94) | 19 (5) | 5 (1) | 372 (22) | 305 (82) | 67 (18) |
 Total | 1688 (100) | 1562 (93) | 89 (5) | 37 (2) | 1689 (100) | 1388 (82) | 301 (18) |
ART Initiation period | |||||||
 2009 and before | 1062 (63) | 1004 (95) | 34 (3) | 24 (2) | 1063 (63) | 892 (84) | 171 (16) |
 2010–2012 | 502 (30) | 447 (89) | 44 (9) | 11 (2) | 502 (30) | 400 (80) | 102 (20) |
 2013–2016 | 123 (7) | 110 (89) | 11 (9) | 2 (2) | 123 (7) | 96 (78) | 27 (22) |
 Total | 1687 (100) | 1561 (93) | 89 (5) | 37 (2) | 1688 (100) | 1388 (82) | 300 (18) |
TB Screening | |||||||
 Negative | 1458 (86) | 1356 (93) | 75 (5) | 27 (2) | 1459 (86) | 1213 (83) | 246 (17) |
 Positive | 151 (9) | 138 (91) | 8 (5) | 5 (3) | 151 (9) | 111 (74) | 40 (26) |
 N/A | 79 (5) | 68 (86) | 6 (8) | 5 (6) | 79 (5) | 64 (81) | 15 (19) |
 Total | 1688 (100) | 1562 (93) | 89 (5) | 37 (2) | 1689 (100) | 1388 (82) | 301 (18) |
Body mass index | |||||||
 Normal weight | 964 (57) | 894 (93) | 50 (5) | 20 (2) | 965 (57) | 783 (81) | 182 (19) |
 Underweight | 186 (11) | 165 (89) | 13 (7) | 8 (4) | 186 (11) | 144 (77) | 42 (23) |
 overweight & Obese | 538 (32) | 503 (93) | 26 (5) | 9 (2) | 538 (32) | 461 (86) | 77 (14) |
 Total | 1688 (100) | 1562 (93) | 89 (5) | 37 (2) | 1689 (100) | 1388 (82) | 301 (18) |
Median CD4 (IQR) | 418 (248, 618) | ||||||
  >  500 cells/mm3 | 638 (38) | 606 (95) | 26 (4) | 6 (1) | 638 (38) | 599 (94) | 39 (6) |
  ≤ 500 cells/mm3 | 1050 (62) | 956 (91) | 63 (6) | 31 (3) | 1051 (62) | 789 (75) | 262 (25) |
 Total | 1688 (100) | 1562 (93) | 89 (5) | 37 (2) | 1689 (100) | 1388 (82) | 301 (18) |
WHO stage | |||||||
 Stage 1–2 | 1042 (62) | 971 (93) | 51 (5) | 20 (2) | 1042 (62) | 881 (85) | 161 (15) |
 Stage 3–4 | 623 (37) | 570 (91) | 36 (6) | 17 (3) | 624 (37) | 489 (78) | 135 (22) |
 missing | 23 (1) | 21 (91) | 2 (9) | 0 (0) | 23 (1) | 18 (78) | 5 (22) |
 Total | 1688 (100) | 1562 (93) | 89 (5) | 37 (2) | 1689 (100) | 1388 (82) | 301 (18) |
Second-line ARV regimen | |||||||
 LPV/r + dual NRTI | 1097 (65) | 1011 (92) | 55 (5) | 31 (3) | 1098 (65) | 920 (84) | 178 (16) |
 ATV/r + dual NRTI | 591 (35) | 551 (93) | 34 (6) | 6 (1) | 591 (35) | 468 (79) | 123 (21) |
 Total | 1688 (100) | 1562 (93) | 89 (5) | 37 (2) | 1689 (100) | 1388 (82) | 301 (18) |
Median VL (IQR) | 20 (20, 100) | Â | Â | Â | Â | Â | Â |
Viral load results | |||||||
  ≤ 20 copies/mL | 1056 (63) | 1002 (95) | 43 (4) | 11 (1) |  |  |  |
 21–1000 copies/mL | 331 (20) | 303 (92) | 20 (6) | 8 (2) |  |  |  |
  > 1000 copies/mL | 301 (18) | 257 (85) | 26 (9) | 18 (6) |  |  |  |
 Total | 1688 (100) | 1562 (93) | 89 (5) | 37 (2) |  |  |  |
Retention | |||||||
 Retained |  |  |  |  | 1562 (93) | 1305 (84) | 257 (16) |
 Not retained |  |  |  |  | 126 (7) | 82 (65) | 44 (35) |
 Total |  |  |  |  | 1688 (100) | 1387 (82) | 301 (18) |